🔍 Pharmaceutical Advertising Regulation: Material Creation, Review & Use in Japan JP/EN
Ethics · Regulation · Technology — Pharma Practice Notes

The Capitalist's View — Investment and Profit — 10-Volume Series

The people on the other side of material review ultimately act on the logic of those who supply the capital. What do shareholders, founders, institutional investors, and PE want, and why do they demand profit — without knowing that measure, you can read neither management’s decisions nor the motive behind an aggressive claim. Across ten volumes, we connect the basics of the cost of capital, investment decisions, and governance to the work of material review.

01

Who Is the Capitalist? — Mapping Shareholders, Founders, Institutional Investors, and PE

The capitalist is not a monolith. Even among “shareholders,” a founder, a pension fund, and a PE firm differ in time horizon and exit. Mistake who wants what, and the logic of a management decision becomes unreadable.
Available →
02

Why Profit Is Required — The Cost of Capital, an Invisible Rent

Profit is not a leftover. It is the rent on capital. Investors do not lend their money for free. Fall below the expected return, and the business is creating no value.
Available →
03

Before You Invest a Single Yen — NPV, ROIC, and the Hurdle Rate

An investment decision begins with calculation, not instinct. Is NPV positive? Does ROIC clear the hurdle rate? Learn this measure and you see why a promising deal gets rejected.
Available →
04

Risk Carries a Price — The Relationship Between Return and Variance

High returns exist for a reason. Only those who take on risk earn the premium that pays for it. The capitalist does not avoid risk; he prices it and goes to take it.
Available →
05

The Separation of Ownership and Control — The Origin of the Agency Problem

The moment the one who provides the money and the one who moves it are split, a divergence of interest is born. This is the agency problem. The director discipline in corporate law is built to contain that gap.
Available →
06

What Shareholders Can and Cannot Do — Voting Rights, Dividends, Residual Assets

Shareholders are not omnipotent. Corporate law grants them clear rights while drawing a line that keeps them out of daily management. Know the scope of the possible, and you can judge how realistic a demand is.
Available →
07

The Tug-of-War Between the Quarter and the Decade — Short-Termism vs. Long-Term Value

The quarterly number and the ten-year value often point in opposite directions. This tug-of-war lives inside the capitalist too. Before condemning short-termism outright, look at its structure.
Available →
08

Capital Allocation — Dividends, Buybacks, Reinvestment, M&A

Management’s greatest decision is neither a new product nor the organization. It is where to direct the capital earned — dividends, buybacks, reinvestment, or M&A. Capital allocation becomes management’s report card.
Available →
09

The Price of Misconduct — When a Breach of Norms Loads onto the Cost of Capital

Misconduct does not end with a fine. Once trust is damaged, it becomes an annual invoice in the form of the cost of capital. This is the true price of breaking the norms.
Available →
10

Material Review Through the Capitalist’s Eyes — Trust as an Intangible Asset

To the capitalist, material review is no cost center. What review protects is the largest asset that never appears on the balance sheet — trust. Its impairment rebounds onto the cost of capital.
Available →
← Perspectives home